**Question:** Which drug is given to prevent HIV transmission from mother to child:

A. Nevirapine
B. Zidovudine
C. Didanosine
D. Lamivudine

**Correct Answer:** A. Nevirapine

**Core Concept:** Prevention of mother-to-child HIV transmission (PMTCT) is a critical aspect of HIV management, particularly in resource-limited settings. The standard PMTCT regimen involves a combination of antiretroviral drugs to reduce the risk of vertical HIV transmission.

**Why the Correct Answer is Right:** Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used as part of the PMTCT regimen. When given to the mother during labor, it is believed to have a shorter duration of action but a higher plasma concentration. This allows for a single dose to be administered during labor, reducing the frequency of drug administration. Nevirapine's ability to cross the placenta and its impact on HIV replication within the infant are key factors in its use for PMTCT.

**Why Each Wrong Option is Incorrect:**

A. Zidovudine: This is a nucleoside reverse transcriptase inhibitor (NRTI) and is used in the PMTCT regimen as well. However, its duration of action is longer than that of nevirapine, which makes it unsuitable for the single-dose administration during labor.

B. Didanosine: Also an NRTI, didanosine has a similar duration of action as zidovudine and is not ideal for the single-dose regimen during labor.

C. Lamivudine: Another NRTI, lamivudine's duration of action is similar to zidovudine and didanosine, making it unsuitable for single-dose administration during labor.

**Clinical Pearl:** The choice of antiretroviral drugs in the PMTCT regimen depends on factors such as drug properties (e.g., duration of action, plasma concentration), local resources, and the specific HIV strain present. In some cases, a triple-drug regimen (including NNRTI, NRTI, and protease inhibitor) may be used. However, for the purposes of this explanation, we focus on the use of nevirapine as a single-dose option during labor.

**Explanation:**

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is a cornerstone of the World Health Organization (WHO) recommended PMTCT regimen. Nevirapine's unique properties make it suitable for the single-dose administration during labor, reducing the frequency of drug administration while still providing effective prophylaxis against HIV transmission to the neonate.

Nevirapine's mechanism of action involves inhibiting the HIV reverse transcriptase enzyme, thereby preventing the replication of the virus in the infant. The single-dose administration during labor ensures that the drug reaches the infant and provides protection against HIV infection.

**Why Each Wrong Option is Inaccurate:**

- Zidovudine and didanosine are nucleoside